SBC Medical Group (SBC)
NASDAQ: SBC
· Real-Time Price · USD
4.22
0.16 (3.94%)
At close: Aug 15, 2025, 10:03 AM
SBC Medical Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | 43.36M | 47.33M | 44.42M | 53.08M | 53.1M | 54.81M | 62.35M | 47.28M | 41M | 42.91M |
Cost of Revenue | 13.82M | 9.6M | 10.55M | 9.85M | 13.68M | 15.29M | 18.98M | 13.78M | 9.08M | 14.4M |
Gross Profit | 29.54M | 37.73M | 33.87M | 43.24M | 39.42M | 39.52M | 43.37M | 33.5M | 31.92M | 28.52M |
Operating Income | 14.55M | 24.2M | 4.72M | 13.83M | 27.29M | 24.46M | 23.99M | 20.02M | 15.57M | 11.08M |
Interest Income | 22.88K | 55.33K | -35.03K | 7.95K | 11.64K | 17.69K | 403.00 | 10.23K | n/a | n/a |
Pretax Income | 13.54M | 31.45M | 6.06M | 13.11M | 27.09M | 27.2M | 23.57M | 21.07M | 16.67M | 12.27M |
Net Income | 2.46M | 21.5M | 6.54M | 2.83M | 18.48M | 18.76M | 14.34M | 8.36M | 10.67M | 6M |
Selling & General & Admin | 14.98M | 12.82M | 13.9M | 29.25M | 11.83M | 14.96M | 19.35M | 13.45M | 16.19M | 17.25M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 706.87K | 15.25M | 151.61K | 300.89K | 100.06K | 28.26K | 28.52K | 160.2K | 192.05K |
Operating Expenses | 14.98M | 13.53M | 29.15M | 29.4M | 12.13M | 15.06M | 19.38M | 13.48M | 16.35M | 17.44M |
Interest Expense | 49.65K | 6.21K | 12.4K | 5.47K | 7.42K | 3.01K | 7.91K | 3.98K | n/a | n/a |
Selling & Marketing Expenses | n/a | 682.17K | 1.23M | 621.76K | 844.85K | 711.63K | n/a | n/a | n/a | n/a |
Cost & Expenses | 28.8M | 23.13M | 39.7M | 39.25M | 25.81M | 30.35M | 38.36M | 27.26M | 25.43M | 31.84M |
Income Tax Expense | 11.1M | 9.96M | -488.55K | 10.27M | 8.53M | 8.45M | 9.34M | 13.01M | 6.81M | 5.86M |
Shares Outstanding (Basic) | 103.51M | 103.28M | 102.75M | 95.1M | 95.1M | 7.95M | 100.74M | 100.74M | 7.95M | n/a |
Shares Outstanding (Diluted) | 103.51M | 103.28M | 102.75M | 95.1M | 95.1M | 7.95M | 100.74M | 100.74M | 7.95M | n/a |
EPS (Basic) | 0.02 | 0.21 | 0.06 | 0.03 | 0.20 | 2.36 | 0.14 | 0.08 | 1.34 | n/a |
EPS (Diluted) | 0.02 | 0.21 | 0.06 | 0.03 | 0.20 | 2.36 | 0.14 | 0.08 | 1.34 | n/a |
EBITDA | 14.2M | 32.09M | 7M | 14.13M | 28.12M | 28.22M | 26.13M | 24.36M | 19.17M | 13.87M |
EBIT | 13.59M | 31.46M | 6.07M | 13.11M | 27.09M | 27.21M | 23.57M | 21.07M | 15.57M | 11.08M |
Depreciation & Amortization | 605.23K | 628.3K | 931.6K | 1.02M | 830.95K | 1.02M | 2.56M | 3.29M | 3.6M | 2.8M |